Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm. Hunter AM, Patnaik MM, Itzykson R, Mesa R, et al. Blood 2024;144:1987-1992.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hunter AM, Patnaik MM, Itzykson R, Mesa R, et al. Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm. Blood 2024;144:1987-1992.
PMID: 39509115